Dr. Von Roenn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
675 N Saint Clair St
# Galter
Chicago, IL 60611Phone+1 312-695-0990Fax+1 312-695-6189
Education & Training
- Rush University Medical CenterFellowship, Hematology and Medical Oncology, 1983 - 1985
- Rush University Medical CenterResidency, Internal Medicine, 1980 - 1983
- Rush Medical College of Rush University Medical CenterClass of 1980
Certifications & Licensure
- IL State Medical License 1982 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hospice and Palliative Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Publications & Presentations
PubMed
- 278 citationsRandomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma.Parkash S. Gill, J C Wernz, David T. Scadden, P Cohen, G M Mukwaya
Journal of Clinical Oncology. 1996-08-01 - 144 citationsRe-validation and shortening of the Functional Assessment of Anorexia/Cachexia Therapy (FAACT) questionnaire.J. M. Ribaudo, David Cella, Elizabeth A. Hahn, Stephen Lloyd, N S Tchekmedyian
Quality of Life Research. 2000-01-01 - 100 citationsFumagillin analog in the treatment of Kaposi's sarcoma: a phase I AIDS Clinical Trial Group study. AIDS Clinical Trial Group No. 215 Team.Bruce J. Dezube, J H Von Roenn, Jeanne Holden-Wiltse, T W Cheung, Scot C. Remick
Journal of Clinical Oncology. 1998-04-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: